Indaptus Therapeutics, Inc. (INDP)

Latest Insider Confidence Score

2026Q1

50.0
Bullish

Company insider confidence (by quarter)

2021Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Anderson Glen R. 10% Owner 1,190,400 Aug 16, 2023
Linscott Walt Addison Chief Business Officer 75,000 Jan 23, 2024
Waltzman Roger J. 75,000 Jan 23, 2024
Newman Michael James CSO and Director 43,250 Jan 23, 2024
Sassi Nir 40,000 Jan 23, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 26, 2026 Feb 27, 2026 Jabbour Jerome D Director Neutral 52.5 - 0.00% -
Feb 27, 2026 Jabbour Jerome D Director Neutral 52.5 - 0.00% -
Feb 26, 2026 McMurdo Matthew Charles Director Neutral 52.5 - 0.00% -
Feb 11, 2026 Feb 13, 2026 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Jan 20, 2026 Jan 22, 2026 Ben-Tzvi Avraham Director Neutral 90.0 +25,000 25000.00% -
Jan 7, 2026 Jan 22, 2026 NATAN DAVID Director Neutral 52.5 - 0.00% -
Jan 12, 2026 NATAN DAVID Director Neutral 52.5 - 0.00% -
Dec 22, 2025 Dec 29, 2025 Sassi Nir CFO Neutral 90.0 +26,758 100.00% -
Dec 22, 2025 Dec 29, 2025 Meckler Jeffrey A CEO Neutral 90.0 +216,617 1627.23% -
Dec 22, 2025 Dec 29, 2025 Newman Michael James CSO and Director Neutral 90.0 +52,204 106.82% -
Dec 22, 2025 Dec 29, 2025 Linscott Walt Addison COO Neutral 90.0 +54,421 1088420.00% -
Dec 23, 2025 Lazar David E. CEO Neutral 52.5 - 0.00% -
Dec 23, 2025 Ben-Tzvi Avraham Director Neutral 52.5 - 0.00% -
Jul 27, 2025 Jul 29, 2025 Meckler Jeffrey A CEO Neutral 90.0 +6,068 83.77% -
Jun 10, 2025 Jun 11, 2025 Karah Hila Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 Martell Robert Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 Hayes William B Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 Pomerantz Roger Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 Gilbert Mark John Director Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Sassi Nir CFO Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Linscott Walt Addison COO Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Pomerantz Roger Director Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Karah Hila Director Neutral 52.5 - 0.00% -
Apr 10, 2025 Apr 11, 2025 Hayes William B Director Neutral 52.5 - 0.00% -
Nov 25, 2024 Nov 26, 2024 Meckler Jeffrey A CEO Neutral 90.0 +42,553 26.54% -
Oct 9, 2024 Oct 10, 2024 Newman Michael James CSO and Director Neutral 52.5 - 0.00% -
Oct 9, 2024 Oct 10, 2024 Sassi Nir CFO Neutral 52.5 - 0.00% -
Oct 9, 2024 Oct 10, 2024 Waltzman Roger J. Chief Medical Officer Neutral 52.5 - 0.00% -
Oct 9, 2024 Oct 10, 2024 Linscott Walt Addison COO Neutral 52.5 - 0.00% -
Oct 9, 2024 Oct 10, 2024 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Aug 8, 2024 Aug 8, 2024 Meckler Jeffrey A CEO Neutral 90.0 +84,932 112.68% -
Jun 6, 2024 Jun 7, 2024 Karah Hila Director Neutral 52.5 - 0.00% -
Jun 6, 2024 Jun 7, 2024 Gilbert Mark John Director Neutral 52.5 - 0.00% -
Jun 6, 2024 Jun 7, 2024 Pomerantz Roger Director Neutral 52.5 - 0.00% -
Jun 6, 2024 Jun 7, 2024 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Jun 6, 2024 Jun 7, 2024 Martell Robert Director Neutral 52.5 - 0.00% -
Jun 6, 2024 Jun 7, 2024 Hayes William B Director Neutral 52.5 - 0.00% -
Jan 22, 2024 Jan 23, 2024 Linscott Walt Addison COO Neutral 52.5 - 0.00% -
Jan 22, 2024 Jan 23, 2024 Waltzman Roger J. Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 22, 2024 Jan 23, 2024 Sassi Nir CFO Neutral 52.5 - 0.00% -
Jan 22, 2024 Jan 23, 2024 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Jan 22, 2024 Jan 23, 2024 Newman Michael James CSO and Director Neutral 52.5 - 0.00% -
Aug 10, 2023 Aug 16, 2023 Anderson Glen R. 10% Owner Buy 90.0 +103,352 9.51% $216.4K
Aug 7, 2023 Aug 7, 2023 Waltzman Roger J. Chief Medical Officer Neutral 52.5 - 0.00% -
Aug 7, 2023 Waltzman Roger J. Chief Medical Officer Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 Karah Hila Director Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 Hayes William B Director Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 Gilbert Mark John Director Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 Pomerantz Roger Director Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Feb 13, 2023 Feb 14, 2023 Martell Robert Director Neutral 52.5 - 0.00% -
Feb 14, 2023 Martell Robert Director Neutral 52.5 - 0.00% -
Jan 18, 2023 Jan 20, 2023 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Jan 18, 2023 Jan 20, 2023 Linscott Walt Addison Chief Business Officer Neutral 52.5 - 0.00% -
Jan 18, 2023 Jan 20, 2023 Sassi Nir CFO Neutral 52.5 - 0.00% -
Jan 18, 2023 Jan 20, 2023 Newman Michael James CSO and Director Neutral 52.5 - 0.00% -
Jan 31, 2022 Dec 19, 2022 Litchev Boyan Vesselinov Chief Medical Officer Buy 90.0 +1,150 100.00% $2.5K
Nov 18, 2022 Nov 22, 2022 Meckler Jeffrey A CEO Buy 91.3 +10,000 15.30% $18.9K
Sep 30, 2022 Oct 3, 2022 Karah Hila Director Neutral 52.5 - 0.00% -
Sep 30, 2022 Oct 3, 2022 Pomerantz Roger Director Neutral 52.5 - 0.00% -
Sep 30, 2022 Oct 3, 2022 Gilbert Mark John Director Neutral 52.5 - 0.00% -
Sep 30, 2022 Oct 3, 2022 O'CALLAGHAN BRIAN Director Neutral 52.5 - 0.00% -
Sep 30, 2022 Oct 3, 2022 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Sep 30, 2022 Oct 3, 2022 Hayes William B Director Neutral 52.5 - 0.00% -
Sep 8, 2022 Sep 12, 2022 Meckler Jeffrey A CEO Buy 91.3 +10,308 18.72% $28.9K
Sep 7, 2022 Sep 9, 2022 Linscott Walt Addison Chief Business Officer Buy 90.0 +150 100.00% $393
Sep 6, 2022 Sep 8, 2022 Meckler Jeffrey A CEO Buy 91.3 +9,692 21.36% $24.8K
Jul 7, 2022 Anderson Glen R. 10% Owner Neutral 52.5 - 0.00% -
Jun 6, 2022 Jun 7, 2022 Meckler Jeffrey A CEO Buy 95.0 +19,727 76.92% $51.9K
Feb 25, 2022 Feb 28, 2022 Sassi Nir CFO Neutral 52.5 - 0.00% -
Feb 1, 2022 Feb 2, 2022 Litchev Boyan Vesselinov Chief Medical Officer Neutral 52.5 - 0.00% -
Feb 2, 2022 Litchev Boyan Vesselinov Chief Medical Officer Neutral 52.5 - 0.00% -
Jan 31, 2022 Feb 2, 2022 Newman Michael James CSO and Director Sell 45.0 -20,000 -1.44% $100K
Jan 26, 2022 Jan 28, 2022 Newman Michael James CSO and Director Neutral 52.5 - 0.00% -
Jan 26, 2022 Jan 28, 2022 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Jan 26, 2022 Jan 28, 2022 Linscott Walt Addison Chief Business Officer Neutral 52.5 - 0.00% -
Dec 1, 2021 Dec 8, 2021 Gilbert Mark John Director Neutral 52.5 - 0.00% -
Dec 8, 2021 Gilbert Mark John Director Neutral 52.5 - 0.00% -
Nov 18, 2021 Nov 19, 2021 Meckler Jeffrey A CEO Buy 95.0 +11,187 77.37% $65.1K
Sep 14, 2021 Sep 16, 2021 Meckler Jeffrey A CEO Buy 95.0 +12,000 487.80% $84K
Aug 4, 2021 Aug 6, 2021 O'CALLAGHAN BRIAN Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Sassi Nir CFO Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Lee Hoonmo Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Hayes William B Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Linscott Walt Addison Chief Business Officer Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Newman Michael James CSO and Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Pomerantz Roger Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 MADDALUNA ANTHONY J Director Neutral 52.5 - 0.00% -
Aug 4, 2021 Aug 6, 2021 Karah Hila Director Neutral 52.5 - 0.00% -
Aug 6, 2021 O'CALLAGHAN BRIAN Director Neutral 52.5 - 0.00% -
Aug 6, 2021 Lee Hoonmo Director Neutral 52.5 - 0.00% -
Aug 6, 2021 Newman Michael James Chief Scientific Officer Neutral 52.5 - 0.00% -
Aug 2, 2021 Hayes William B Director Neutral 52.5 - 0.00% -
Aug 2, 2021 Karah Hila Director Neutral 52.5 - 0.00% -
Aug 2, 2021 Meckler Jeffrey A CEO Neutral 52.5 - 0.00% -
Aug 2, 2021 Linscott Walt Addison Chief Business Officer Neutral 52.5 - 0.00% -